跳至主要内容
临床试验/NCT00238342
NCT00238342Unknown不适用

Pelvic Mass Study to Develop Serum Proteomic Profiles (SIGNATURES) for Epithelial Ovarian Cancer Diagnosis and Prognosis

Gynecologic Oncology Group214 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2005年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
2,000
试验地点
214
主要终点
Proteomic proflie (i.e. discrimination of tumor from nontumor in pelvic mass)

研究概览

简要总结

RATIONALE: Finding specific proteins in the blood may help doctors tell whether a patient has ovarian cancer.

PURPOSE: This clinical trial is studying how well proteomic profiling works in diagnosing ovarian cancer in patients who are undergoing surgery for an abnormal pelvic mass.

详细描述

OBJECTIVES:

Primary

  • Generate and validate a serum proteomic profile that can predict the presence of invasive ovarian epithelial cancer using preoperative serum specimens obtained from patients undergoing surgical evaluation for an abnormal pelvic mass.

Secondary

  • Generate a proteomic profile that can distinguish early- from late-stage invasive ovarian epithelial cancer using preoperative serum specimens from patients who are subsequently diagnosed with invasive ovarian epithelial cancer.

研究设计

研究类型
Interventional
主要目的
Diagnostic

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Proteomic proflie (i.e. discrimination of tumor from nontumor in pelvic mass)

次要结局

未报告次要终点

研究者

申办方类型
Network

研究点 (214)

Loading locations...

相似试验